Valuation: Lifestyle Delivery Systems Inc

Market Cap 10.2M 7.28M 6.36M 5.87M 5.41M 701M 10.42M 70.16M 27.6M 343M 27.34M 26.74M 1.18B P/E 2022 *
-
P/E 2023 -0.92x
Enterprise Value 9.74M 6.95M 6.08M 5.61M 5.17M 670M 9.96M 67.02M 26.36M 328M 26.11M 25.54M 1.13B EV / Sales 2022 *
-
EV / Sales 2023 43x
Free-Float
99.7%
Yield 2022 *
-
Yield 2023 -
Change 5-day change 1-year change 3-year change Capi.($)
-11.17%-38.75% - - 47
-1.32%+5.33%-8.55%-5.18% 13.54B
-3.30%+9.97%-27.67%-49.81% 5.27B
-2.47%+7.14%+0.62%-4.09% 4.72B
-5.06%+6.38%+8.55%-32.43% 4.07B
-2.65%+2.32%+4.01%-8.76% 3.75B
0.00%+9.56%-4.89%-3.35% 3.57B
-3.45%+9.23%-5.06%+7.03% 3.39B
-3.77%+0.45%-13.12%-22.74% 2.42B
-2.82%+3.13%-1.88%+49.73% 1.86B
Average -3.60%+2.57%-5.33%-7.73% 4.73B
Weighted average by Cap. -2.43%+3.08%-6.55%-10.97%

Financials

2021 2022 *
Net sales 432K 308K 269K 248K 229K 29.67M 441K 2.97M 1.17M 14.53M 1.16M 1.13M 50.02M -
Net income -37.05M -26.45M -23.11M -21.33M -19.66M -2.55B -37.88M -255M -100M -1.25B -99.33M -97.15M -4.29B -
Net Debt -843K -602K -526K -485K -447K -57.97M -862K -5.8M -2.28M -28.39M -2.26M -2.21M -97.74M -
Logo Lifestyle Delivery Systems Inc
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.
Employees
-